GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Essa Pharma Inc (EPIX) [hlAlert]

Rating:
Outperform
EPIX
up 84.56 %

Epix Pharmaceuticals, Inc. (EPIX) rated Outperform with price target $6 by RBC Capital Mkts

Posted on: Wednesday,  Jan 16, 2008  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Essa Pharma Inc (NASDAQ: EPIX) on 01/16/2008, when the stock price was $3.11.
Since then, Essa Pharma Inc has gained 84.57% as of 08/27/2015's recent price of $5.74.
If you would have followed this RBC Capital Mkts's recommendation on EPIX, you would have gained 84.56% of your investment in 2780 days.

EPIX Pharmaceuticals, Inc., based in Cambridge, MA, discovers and develops innovative pharmaceuticals for imaging that are designed to transform the diagnosis, treatment and monitoring of disease. They use their proprietary Target Visualization Technology to create imaging pharmaceuticals targeted at the molecular level, enabling physicians to use Magnetic Resonance Imaging to obtain detailed information about specific disease processes. The Company's lead product, MS-325, is the first imaging pharmaceutical specifically designed for Magnetic Resonance Angiography.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/16/2008 9:25 AM Buy
None
3.11 6.00
as of 12/24/2008
1 Week   
1 Month down  -22.72 %
3 Months down  -56.96 %
1 YTD down  -66.99 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy